Tuberculous peritonitis in peritoneal dialysis: report of three cases

Safae Boughlala, Mina Agrou, Latifa Driouch, N. Ouzeddoun, R. Bayahia, L. Benamar
{"title":"Tuberculous peritonitis in peritoneal dialysis: report of three cases","authors":"Safae Boughlala, Mina Agrou, Latifa Driouch, N. Ouzeddoun, R. Bayahia, L. Benamar","doi":"10.25796/bdd.v5i1.64573","DOIUrl":null,"url":null,"abstract":"Tuberculous peritonitis is a rare but dreaded complication in peritoneal dialysis. \nWe report three cases of tuberculous peritonitis diagnosed in our PD center at over a period of 15 years. \nThey are a woman and two men aged 50, 45 and 64 respectively. \nThe diagnosis of tuberculous peritonitis was suspected in front of a many of clinical (AEG, abdominal pain, cloudy liquid), biological (inflammatory syndrome, the dialysate liquid with lymphocyte predominance and negative culture) and or radiological (abdominal lymphadenopathy) arguments. \nIt was confirmed by the demonstration of Mycobacterium Tuberculosis in the dialysate by GeneXpert or by culture on LOWENSTEIN Jensen medium in 2 cases, and the characteristic appearance on anatomopathological examination in only 1 case. \nThe evolution under antituberculous treatment was favorable, with recourse to the ablation of \nThe diagnosis of tuberculous peritonitis in peritoneal dialysis is difficult and often late because the clinical signs is non-specific. It should be considered in the presence of any culture-negative peritonitis that is refractory to empirical treatment. \nBacteriological or histological confirmation should not delay the start of anti-tuberculosis treatment because early diagnosis and rapid initiation of treatment are the keys to recovery and the only guarantee of a good prognosis.","PeriodicalId":366938,"journal":{"name":"Bulletin de la Dialyse à Domicile","volume":"16 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin de la Dialyse à Domicile","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25796/bdd.v5i1.64573","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Tuberculous peritonitis is a rare but dreaded complication in peritoneal dialysis. We report three cases of tuberculous peritonitis diagnosed in our PD center at over a period of 15 years. They are a woman and two men aged 50, 45 and 64 respectively. The diagnosis of tuberculous peritonitis was suspected in front of a many of clinical (AEG, abdominal pain, cloudy liquid), biological (inflammatory syndrome, the dialysate liquid with lymphocyte predominance and negative culture) and or radiological (abdominal lymphadenopathy) arguments. It was confirmed by the demonstration of Mycobacterium Tuberculosis in the dialysate by GeneXpert or by culture on LOWENSTEIN Jensen medium in 2 cases, and the characteristic appearance on anatomopathological examination in only 1 case. The evolution under antituberculous treatment was favorable, with recourse to the ablation of The diagnosis of tuberculous peritonitis in peritoneal dialysis is difficult and often late because the clinical signs is non-specific. It should be considered in the presence of any culture-negative peritonitis that is refractory to empirical treatment. Bacteriological or histological confirmation should not delay the start of anti-tuberculosis treatment because early diagnosis and rapid initiation of treatment are the keys to recovery and the only guarantee of a good prognosis.
腹膜透析并发结核性腹膜炎3例报告
结核性腹膜炎是腹膜透析中一种罕见但可怕的并发症。我们报告三例结核性腹膜炎诊断在我们的PD中心在超过15年的时间。他们是一名女性和两名男性,年龄分别为50岁、45岁和64岁。结核性腹膜炎的诊断在许多临床(AEG,腹痛,混浊液体),生物学(炎症综合征,淋巴细胞占优势的透析液和阴性培养)和/或放射学(腹部淋巴结病)的争论中被怀疑。2例经GeneXpert透析液或LOWENSTEIN Jensen培养基培养证实为结核分枝杆菌,1例经解剖病理检查有特征性表现。由于临床症状无特异性,腹膜透析中结核性腹膜炎的诊断困难且往往较晚。应考虑存在任何培养阴性腹膜炎,难以经验性治疗。细菌学或组织学证实不应延误抗结核治疗的开始,因为早期诊断和迅速开始治疗是康复的关键,也是良好预后的唯一保证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信